|
1
|
Schols A: Nutritional modulation as part
of the integrated management of chronic obstructive pulmonary
disease. Proc Nutr Soc. 62:783–791. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cao C, Wang R, Wang J, Bunjhoo H, Xu Y and
Xiong W: Body mass index and mortality in chronic obstructive
pulmonary disease: A meta-analysis. PLoS One. 7:e438922012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wagner PD: Possible mechanisms underlying
the development of cachexia in COPD. Eur Respir J. 31:492–501.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
McCarthy B, Casey D, Devane D, Murphy K,
Murphy E and Lacasse Y: Pulmonary rehabilitation for chronic
obstructive pulmonary disease. Cochrane Database Syst Rev.
CD003793:2015.
|
|
5
|
Ferreira IM, Brooks D, White J and
Goldstein R: Nutritional supplementation for stable chronic
obstructive pulmonary disease. Cochrane Database Syst Rev.
12:CD0009982012.PubMed/NCBI
|
|
6
|
Sugawara K, Takahashi H, Kasai C, Kiyokawa
N, Watanabe T, Fujii S, Kashiwagura T, Honma M, Satake M and Shioya
T: Effects of nutritional supplementation combined with
low-intensity exercise in malnourished patients with COPD. Respir
Med. 104:1883–1889. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sugawara K, Takahashi H, Kashiwagura T,
Yamada K, Yanagida S, Homma M, Dairiki K, Sasaki H, Kawagoshi A,
Satake M and Shioya T: Effect of anti-inflammatory supplementation
with whey peptide and exercise therapy in patients with COPD.
Respir Med. 106:1526–1534. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Miki K, Maekura R, Nagaya N, Nakazato M,
Kimura H, Murakami S, Ohnishi S, Hiraga T, Miki M, Kitada S, et al:
Ghrelin treatment of cachectic patients with chronic obstructive
pulmonary disease: A multicenter, randomized, double-blind,
placebo-controlled trial. PLoS One. 7:e357082012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Creutzberg EC, Schols AM, Weling-Scheepers
CA, Buurman WA and Wouters EF: Characterization of nonresponse to
high caloric oral nutritional therapy in depleted patients with
chronic obstructive pulmonary disease. Am J Respir Crit Care Med.
161:745–752. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kuroiwa A, Liou S, Yan H, Eshita A, Naitoh
S and Nagayama A: Effect of a traditional Japanese herbal medicine,
hochu-ekki-to (Bu-Zhong-Yi-Qi Tang), on immunity in elderly
persons. Int Immunopharmacol. 4:317–324. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Satoh N, Sakai S, Kogure T, Tahara E,
Origasa H, Shimada Y, Kohoda K, Okubo T and Terasawa K: A
randomized double blind placebo-controlled clinical trial of
Hochuekkito, a traditional herbal medicine, in the treatment of
elderly patients with weakness N of one and responder restricted
design. Phytomedicine. 12:549–554. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mori K, Kido T, Daikuhara H, Sakakibara I,
Sakata T, Shimizu K, Amagaya S, Sasaki H and Komatsu Y: Effect of
Hochu-ekki-to (TJ-41), a Japanese herbal medicine, on the survival
of mice infected with influenza virus. Antiviral Res. 44:103–111.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tajima S, Bando M, Yamasawa H, Ohno S,
Moriyama H, Takada T, Suzuki E, Gejyo F and Sugiyama Y: Preventive
effect of Hochu-ekki-to on lipopolysaccharide-induced acute lung
injury in BALB/c mice. Lung. 184:318–323. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tajima S, Bando M, Yamasawa H, Ohno S,
Moriyama H, Terada M, Takada T, Suzuki E, Gejyo F and Sugiyama Y:
Preventive effect of hochu-ekki-to, a Japanese herbal medicine, on
bleomycin-induced lung injury in mice. Respirology. 12:814–822.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tatsumi K, Shinozuka N, Nakayama K, Sekiya
N, Kuriyama T and Fukuchi Y: Hochuekkito improves systemic
inflammation and nutritional status in elderly patients with
chronic obstructive pulmonary disease. J Am Geriatr Soc.
57:169–170. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Global initiative for chronic obstructive
lung disease: Global strategy for the diagnosis, management, and
prevention of chronic obstructive pulmonary disease. 2018 Report.
http://www.goldcopd.orgJuly
12–2018
|
|
17
|
ATS Committee on Proficiency Standards for
Clinical Pulmonary Function Laboratories, . ATS statement:
Guidelines for the six-minute walk test. Am J Respir Crit Care Med.
166:111–117. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Holland AE, Spruit MA, Troosters T, Puhan
MA, Pepin V, Saey D, McCormack MC, Carlin BW, Sciurba FC, Pitta F,
et al: An official European Respiratory Society/American Thoracic
Society technical standard: Field walking tests in chronic
respiratory disease. Eur Respir J. 44:1428–1446. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Miller MR, Hankinson J, Brusasco V, Burgos
F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP,
Gustafsson P, et al: Standardisation of spirometry. Eur Respir J.
26:319–338. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Celli BR and MacNee W; ATS/ERS Task Force,
. Standards for the diagnosis and treatment of patients with COPD:
A summary of the ATS/ERS position paper. Eur Respir J. 23:932–946.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jones PW, Harding G, Berry P, Wiklund I,
Chen WH and Kline Leidy N: Development and first validation of the
COPD Assessment Test. Eur Respir J. 34:648–654. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Glaxo Smith Kline group of companies. COPD
Asessment Test 2016. http://www.catestonline.orgJuly 12–2018
|
|
23
|
Vogelmeier C, Hederer B, Glaab T, Schmidt
H, Rutten-van Mölken MP, Beeh KM, Rabe KF and Fabbri LM; POET-COPD
investigators, . Tiotropium versus salmeterol for the prevention of
exacerbations of COPD. N Engl J Med. 364:1093–1103. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen Y, Shergis JL, Wu L, Yu X, Zeng Q, Xu
Y, Guo X, Zhang AL, Xue CC and Lin L: A systematic review and
meta-analysis of the herbal formula Buzhong Yiqi Tang for stable
chronic obstructive pulmonary disease. Complement Ther Med.
29:94–108. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jeong JS, Ryu BH, Kim JS, Park JW, Choi WC
and Yoon SW: Bojungikki-tang for cancer-related fatigue: A pilot
randomized clinical trial. Integr Cancer Ther. 9:331–338. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Enomoto Y, Hagiwara E, Komatsu S,
Nishihira R, Baba T, Kitamura H, Sekine A, Nakazawa A and Ogura T:
Pilot quasi-randomized controlled study of herbal medicine
Hochuekkito as an adjunct to conventional treatment for progressed
pulmonary Mycobacterium avium complex disease. PLoS One.
9:e1044112014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Katsura H, Yamada K and Kida K: Both
generic and disease specific health-related quality of life are
deteriorated in patients with underweight COPD. Respir Med.
99:624–630. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kunik ME, Roundy K, Veazey C, Souchek J,
Richardson P, Wray NP and Stanley MA: Surprisingly high prevalence
of anxiety and depression in chronic breathing disorders. Chest.
127:1205–1211. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hanania NA, Müllerova H, Locantore NW,
Vestbo J, Watkins ML, Wouters EF, Rennard SI and Sharafkhaneh A;
Evaluation of COPD Longitudinally to Identify Predictive Surrogate
Endpoints (ECLIPSE) study investigators, . Evaluation of COPD
Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE)
study investigators. Determinants of depression in the ECLIPSE
chronic obstructive pulmonary disease cohort. Am J Respir Crit Care
Med. 183:604–611. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tohda M and Mingmalairak S: Evidence of
antidepressive effects of a Wakan-yaku, Hochuekkito, in depression
model mice with learned-helplessness behavior. Evid Based
Complement Alternat Med. 2013:3190732013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Baarends EM, Schols AM, Mostert R and
Wouters EF: Peak exercise response in relation to tissue depletion
in patients with chronic obstructive pulmonary disease. Eur Respir
J. 10:2807–2813. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sabino PG, Silva BM and Brunetto AF:
Nutritional status is related to fat-free mass, exercise capacity
and inspiratory strength in severe chronic obstructive pulmonary
disease patients. Clinics (Sao Paulo). 65:599–605. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Franssen FM, Broekhuizen R, Janssen PP,
Wouters EF and Schols AM: Limb muscle dysfunction in COPD: Effects
of muscle wasting and exercise training. Med Sci Sports Exerc.
37:2–9. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Teopompi E, Tzani P, Aiello M, Ramponi S,
Andrani F, Marangio E, Clini E and Chetta A: Fat-free mass
depletion is associated with poor exercise capacity irrespective of
dynamic hyperinflation in COPD patients. Respir Care. 59:718–725.
2014. View Article : Google Scholar : PubMed/NCBI
|
